Arterial Occlusive Diseases  >>  Zontivity (vorapaxar)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zontivity (vorapaxar) / Merck (MSD)
NCT02629367: Influence of Vorapaxar on Thrombin Generation and Coagulability

Not yet recruiting
4
100
US
Vorapaxar, Asprin, Clopidogrel
Inova Health Care Services
Coronary Artery Disease
01/17
03/17
NCT02975583: Vorapaxar and Lower Extremity Bypass Grafts

Withdrawn
4
0
NA
Vorapaxar, Zontivity, Placebos, Placebo
Vanderbilt University, Merck Sharp & Dohme LLC
Peripheral Artery Disease
01/18
01/18

Download Options